台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    96.1
  • 漲跌
    ▲0.9
  • 漲幅
    +0.95%
  • 成交量
    522
  • 產業
    上櫃 生技醫療類股
  • 306人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智擎 (4162)籌碼相關-凱基 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/091995.461994.8194.6001,3410.00%
2025/01/0700.0047100.86101.50-471,275-3.69%
2024/12/12190.3000.0090.2011,1990.08%
2024/11/291595.851597.2397.5001,1360.00%
2024/11/2200.00795.1093.80-71,031-0.68%
2024/11/2000.00096.7096.5001,0180.00%
2024/11/19096.6500.0096.0001,0150.00%
2024/11/144105.0020104.53101.50-16971-1.65%
2024/11/133106.5000.00106.5039460.32%
2024/11/0700.0016104.53103.50-16852-1.88%
2024/11/0600.00134106.04102.50-134826-16.21% 大賣/鉅額交易
2024/11/0520104.2300.00106.00207822.56%
2024/11/0412105.7500.00100.00127581.58%
2024/11/0154108.0500.00105.00547307.39%
2024/10/3070101.9900.00102.007061711.34%
2024/10/2969101.0000.00100.506960411.41%
2024/10/2811100.5000.00102.00115761.91%
2024/10/247799.8800.0098.307749415.57%
2024/10/231891.4700.0093.70184244.24%
2024/10/141888.8400.0089.20184983.61%
2024/08/0600.00778.6980.80-7783-0.89%
2024/07/18498.7300.0099.4046760.59%
2024/05/3000.00590.8090.30-5737-0.68%
2024/05/17398.1300.0097.9038720.34%
2024/05/0200.000.194.8094.90-0.11,414-0.01%
2024/04/30093.2000.0093.7001,4250.00%
2024/04/2900.000.193.5095.30-0.11,430-0.01%
2024/04/2500.00091.8090.6001,4490.00%
2024/04/2400.00090.9090.7001,4550.00%
2024/04/190.190.2300.0089.000.11,5230.00%
2024/04/1800.000.193.7093.60-0.11,5250.00%
2024/04/16091.5400.0091.0001,5570.00%
2024/04/1500.00294.4594.10-21,565-0.13%
2024/04/11298.1500.0097.9021,6150.12%
2024/04/02299.5500.0098.9021,7800.11%
2024/03/2900.001698.6199.20-161,813-0.88%
2024/03/2800.001399.9699.40-131,839-0.71%
2024/03/2729100.2900.0099.70291,8281.59%
2024/03/1800.00393.4793.30-31,855-0.16%
2024/03/1400.00592.8292.70-51,882-0.27%
2024/03/13093.85893.1192.40-81,896-0.42%
2024/03/1200.001795.6695.60-171,889-0.90%
2024/03/1100.00495.1095.10-41,904-0.21%
2024/03/0800.00296.1095.10-21,924-0.10%
2024/03/07096.151995.4499.30-191,930-0.98%
2024/03/06098.6000.0098.1001,9370.00%
2024/03/0100.0023102.33101.50-231,939-1.19%
2024/02/2900.0055102.00103.50-551,986-2.77%
2024/02/271104.0000.00103.0011,9950.05%
2024/02/2600.000104.00104.5001,9900.00%
2024/02/2200.007101.00101.00-72,018-0.35%
2024/02/2130102.1000.00101.50302,0431.47%
2024/02/1900.0016101.72101.50-162,075-0.77%
2024/02/160102.5021101.74102.00-212,096-1.00%
2024/02/1500.0024109.88110.50-242,060-1.16%
2024/02/0200.0012105.00105.50-122,216-0.54%
2024/02/0100.0024106.98107.00-242,281-1.05%
2024/01/311105.0025106.00106.00-242,396-1.00%
智擎明、後年新藥將有斬獲 歐洲藥證+一期臨床數據結果Anue鉅亨-2023/11/03
智擎 相關文章